Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 45
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Using high-tech toys to improve foraging in captive rhinos

    A Foobler is a toy that dispenses food when your pet plays with it. We want to build one for the San Francisco...

    Why do daddy longlegs fight during mating?

    Have you ever wondered why some animals cooperate and others fight? I am studying cooperation and conflict during...

    Backer Badge Funded